High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry

Murali Subramanian, Angela K Birnbaum, Rory P Remmel

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Therapeutic drug monitoring of antiepileptic drugs (AEDs) is important and widely practiced. However, simultaneous AED assays usually concentrate only on old or new AEDs. A new simultaneous assay was developed to monitor both older and newer AEDs in the same sample. This assay measures zonisamide (ZNS), lamotrigine (LTG), topiramate (TPM), phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ), carbamazepine-10,11-diol (CBZ-Diol), 10- hydroxycarbamazepine (MHD), and carbamazepine-10,11-epoxide (CBZ-E). Sample pretreatment consisted of a single solid-phase extraction (SPE) for all AEDs in a 100-μL plasma sample. HPLC separation was achieved on a Shimdazu Shimpack XR-ODS (4.6 id × 50 mm, 2.2-μm) column with a gradient mobile phase of acetate buffer, methanol, acetonitrile, and tetrahydrofuran. Four internal standards were used. Detection was achieved by atmospheric pressure chemical ionization mass spectrometry (APCI-MS) in selected-ion monitoring (SIM) mode with constant polarity switching. High recovery (88%-96%) was obtained for all compounds by SPE. Linearity was observed throughout an 80-fold concentration range, with correlation coefficient (r 2) values higher than 0.99 for all AEDs. For the standards, the accuracy ranged from 89.3% to 111.8%. The within-run coefficient of variation (CV w) value was ≤9.7%, the between-run coefficient of variation (CV b) was ≤16.2%, and the total variability (CV t) was ≤16.8%. For the quality controls (QCs), accuracy ranged from 89.3% to 108.8%, CV w was ≤9.6%, CV b was ≤14.1%, and CV t was ≤15.1%. The correlation r 2 values for comparison of this assay with existing validated assays in our laboratory (GC-MS or LC-MS) were 0.95, 0.91, 0.87, 0.95, and 0.95 for PHT, LTG, CBZ, CBZ-E, and CBZ-Diol, respectively.

Original languageEnglish (US)
Pages (from-to)347-356
Number of pages10
JournalTherapeutic Drug Monitoring
Volume30
Issue number3
DOIs
StatePublished - Jun 1 2008

Fingerprint

Liquid chromatography
Liquid Chromatography
Anticonvulsants
Mass spectrometry
Mass Spectrometry
Carbamazepine
Assays
zonisamide
10,11-dihydro-10-hydroxycarbamazepine
Solid Phase Extraction
Phenytoin
Atmospheric Pressure
Monitoring
Drug Monitoring
Phenobarbital
Magnetohydrodynamics
Quality Control
Atmospheric pressure
Ionization
Quality control

Keywords

  • Antiepileptic drugs (AEDs)
  • Carbamazepine
  • LC-MS
  • Lamotrigine
  • Simultaneous assay
  • Solid-phase extraction
  • Zonisamide

Cite this

High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. / Subramanian, Murali; Birnbaum, Angela K; Remmel, Rory P.

In: Therapeutic Drug Monitoring, Vol. 30, No. 3, 01.06.2008, p. 347-356.

Research output: Contribution to journalArticle

@article{7f81118f5a46416e87bd9226d9ade8cd,
title = "High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry",
abstract = "Therapeutic drug monitoring of antiepileptic drugs (AEDs) is important and widely practiced. However, simultaneous AED assays usually concentrate only on old or new AEDs. A new simultaneous assay was developed to monitor both older and newer AEDs in the same sample. This assay measures zonisamide (ZNS), lamotrigine (LTG), topiramate (TPM), phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ), carbamazepine-10,11-diol (CBZ-Diol), 10- hydroxycarbamazepine (MHD), and carbamazepine-10,11-epoxide (CBZ-E). Sample pretreatment consisted of a single solid-phase extraction (SPE) for all AEDs in a 100-μL plasma sample. HPLC separation was achieved on a Shimdazu Shimpack XR-ODS (4.6 id × 50 mm, 2.2-μm) column with a gradient mobile phase of acetate buffer, methanol, acetonitrile, and tetrahydrofuran. Four internal standards were used. Detection was achieved by atmospheric pressure chemical ionization mass spectrometry (APCI-MS) in selected-ion monitoring (SIM) mode with constant polarity switching. High recovery (88{\%}-96{\%}) was obtained for all compounds by SPE. Linearity was observed throughout an 80-fold concentration range, with correlation coefficient (r 2) values higher than 0.99 for all AEDs. For the standards, the accuracy ranged from 89.3{\%} to 111.8{\%}. The within-run coefficient of variation (CV w) value was ≤9.7{\%}, the between-run coefficient of variation (CV b) was ≤16.2{\%}, and the total variability (CV t) was ≤16.8{\%}. For the quality controls (QCs), accuracy ranged from 89.3{\%} to 108.8{\%}, CV w was ≤9.6{\%}, CV b was ≤14.1{\%}, and CV t was ≤15.1{\%}. The correlation r 2 values for comparison of this assay with existing validated assays in our laboratory (GC-MS or LC-MS) were 0.95, 0.91, 0.87, 0.95, and 0.95 for PHT, LTG, CBZ, CBZ-E, and CBZ-Diol, respectively.",
keywords = "Antiepileptic drugs (AEDs), Carbamazepine, LC-MS, Lamotrigine, Simultaneous assay, Solid-phase extraction, Zonisamide",
author = "Murali Subramanian and Birnbaum, {Angela K} and Remmel, {Rory P}",
year = "2008",
month = "6",
day = "1",
doi = "10.1097/FTD.0b013e3181678ecb",
language = "English (US)",
volume = "30",
pages = "347--356",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry

AU - Subramanian, Murali

AU - Birnbaum, Angela K

AU - Remmel, Rory P

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Therapeutic drug monitoring of antiepileptic drugs (AEDs) is important and widely practiced. However, simultaneous AED assays usually concentrate only on old or new AEDs. A new simultaneous assay was developed to monitor both older and newer AEDs in the same sample. This assay measures zonisamide (ZNS), lamotrigine (LTG), topiramate (TPM), phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ), carbamazepine-10,11-diol (CBZ-Diol), 10- hydroxycarbamazepine (MHD), and carbamazepine-10,11-epoxide (CBZ-E). Sample pretreatment consisted of a single solid-phase extraction (SPE) for all AEDs in a 100-μL plasma sample. HPLC separation was achieved on a Shimdazu Shimpack XR-ODS (4.6 id × 50 mm, 2.2-μm) column with a gradient mobile phase of acetate buffer, methanol, acetonitrile, and tetrahydrofuran. Four internal standards were used. Detection was achieved by atmospheric pressure chemical ionization mass spectrometry (APCI-MS) in selected-ion monitoring (SIM) mode with constant polarity switching. High recovery (88%-96%) was obtained for all compounds by SPE. Linearity was observed throughout an 80-fold concentration range, with correlation coefficient (r 2) values higher than 0.99 for all AEDs. For the standards, the accuracy ranged from 89.3% to 111.8%. The within-run coefficient of variation (CV w) value was ≤9.7%, the between-run coefficient of variation (CV b) was ≤16.2%, and the total variability (CV t) was ≤16.8%. For the quality controls (QCs), accuracy ranged from 89.3% to 108.8%, CV w was ≤9.6%, CV b was ≤14.1%, and CV t was ≤15.1%. The correlation r 2 values for comparison of this assay with existing validated assays in our laboratory (GC-MS or LC-MS) were 0.95, 0.91, 0.87, 0.95, and 0.95 for PHT, LTG, CBZ, CBZ-E, and CBZ-Diol, respectively.

AB - Therapeutic drug monitoring of antiepileptic drugs (AEDs) is important and widely practiced. However, simultaneous AED assays usually concentrate only on old or new AEDs. A new simultaneous assay was developed to monitor both older and newer AEDs in the same sample. This assay measures zonisamide (ZNS), lamotrigine (LTG), topiramate (TPM), phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ), carbamazepine-10,11-diol (CBZ-Diol), 10- hydroxycarbamazepine (MHD), and carbamazepine-10,11-epoxide (CBZ-E). Sample pretreatment consisted of a single solid-phase extraction (SPE) for all AEDs in a 100-μL plasma sample. HPLC separation was achieved on a Shimdazu Shimpack XR-ODS (4.6 id × 50 mm, 2.2-μm) column with a gradient mobile phase of acetate buffer, methanol, acetonitrile, and tetrahydrofuran. Four internal standards were used. Detection was achieved by atmospheric pressure chemical ionization mass spectrometry (APCI-MS) in selected-ion monitoring (SIM) mode with constant polarity switching. High recovery (88%-96%) was obtained for all compounds by SPE. Linearity was observed throughout an 80-fold concentration range, with correlation coefficient (r 2) values higher than 0.99 for all AEDs. For the standards, the accuracy ranged from 89.3% to 111.8%. The within-run coefficient of variation (CV w) value was ≤9.7%, the between-run coefficient of variation (CV b) was ≤16.2%, and the total variability (CV t) was ≤16.8%. For the quality controls (QCs), accuracy ranged from 89.3% to 108.8%, CV w was ≤9.6%, CV b was ≤14.1%, and CV t was ≤15.1%. The correlation r 2 values for comparison of this assay with existing validated assays in our laboratory (GC-MS or LC-MS) were 0.95, 0.91, 0.87, 0.95, and 0.95 for PHT, LTG, CBZ, CBZ-E, and CBZ-Diol, respectively.

KW - Antiepileptic drugs (AEDs)

KW - Carbamazepine

KW - LC-MS

KW - Lamotrigine

KW - Simultaneous assay

KW - Solid-phase extraction

KW - Zonisamide

UR - http://www.scopus.com/inward/record.url?scp=47249102459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249102459&partnerID=8YFLogxK

U2 - 10.1097/FTD.0b013e3181678ecb

DO - 10.1097/FTD.0b013e3181678ecb

M3 - Article

C2 - 18520607

AN - SCOPUS:47249102459

VL - 30

SP - 347

EP - 356

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 3

ER -